On January 28, 2019, ReShape Lifesciences Inc. announced that Dan W. Gladney has decided to resign from his role as President and Chief Executive Officer of the company effective as of March 31, 2019. Mr. Gladney will continue to serve as Chairman of the Board of the company. The company's Board of Directors will immediately begin to search for the company's next President and Chief Executive Officer.